| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-09-08 | Yeliva™ (ABC294640) | refractory or relapsed multiple myeloma | 1b/2 | Redhill Biopharma (Israel) | Cancer - Oncology |
| 2016-09-07 | AsiDNA™ | preclinical | Onxeo (France) | Cancer - Oncology | |
| 2016-09-07 | PQ912 | preclinical | Probiodrug (Germany) | Inflammatory diseases | |
| 2016-09-07 | combination of Diamyd®, vitamin D and etanercept | type 1 diabetes | 2 | Diamyd Medical (Sweden) | Metabolic diseases |
| 2016-09-07 | Diamyd® diabetes vaccine | type 1 diabetes | 2 | Diamyd Medical (Sweden) | Metabolic diseases |
| 2016-09-06 | combination of fluticasone furoate, umeclidinium and vilanterol (FF/UMEC/VI) | chronic obstructive pulmonary disease (COPD) | 3 | GSK (UK) Theravance, now Innoviva (USA - CA) | Inflammatory diseases - Respiratory diseases |
| 2016-09-02 | MD1003 (high doses of pharmaceutical-grade biotin) | multiple sclerosis | 3 | Medday (France) | Autoimmune diseases - Neurodegenerative diseases |
| 2016-08-31 | AST-OPC1 (oligodendrocyte progenitor cells) | spinal cord injury | 1-2a | Asterias Biotherapeutics (USA -CA) | Rare diseases - Regenerative medicine |
| 2016-08-30 | TK216 - small molecule Ewing Sarcoma breakpoint region 1/Friend leukemia virus integration 1 fusion protein inhibitor | Ewing sarcoma | 1 | Oncternal Therapeutics (USA - CA) | Cancer - Oncology - Rare diseases |
| 2016-08-30 | ARRY-797 | lamin A/C-related dilated cardiomyopathy | 2 | Array BioPharma (USA - CO) | Cardiovascular diseases - Rare diseases |
| 2016-08-30 | tarextumab (anti-Notch2/3, OMP-59R5) | small cell lung cancer | 1b/2 | OncoMed Pharmaceuticals (USA - CA) GSK (UK) | Cancer - Oncology |
| 2016-08-29 | Prolia® (denosumab) | glucocorticoid-induced osteoporosis | 3 | Amgen (USA - CA) | Bone diseases |
| 2016-08-29 | Praluent® (alirocumab - SAR236553/REGN727) | heterozygous familial hypercholesterolemia (HeFH) | 3 | Sanofi (France) Regeneron Pharmaceuticals (USA - NY) | Cardiovascular diseases - Genetic diseases - Rare diseases |
| 2016-08-29 | Xarelto® (rivaroxaban) | non-valvular atrial fibrillation | post-authorisation observational | Bayer Healthcare (Germany) | Cardiovascular diseases |
| 2016-08-25 | solithromycin | community-acquired bacterial pneumonia (CABP) | 3 | Cempra (USA - NC) | Infectious diseases |
| 2016-08-25 | daratumumab combined with bortezomib and dexamethasone | relapsed or refractory multiple myeloma | 3 | Janssen Biotech - J&J (USA) Genmab (Denmark) | Cancer - Oncology |
| 2016-08-25 | BioChaperone® PDGF-BB (Platelet Derived Growth factor) | diabetic foot ulcer | 3 | Adocia (France) | Metabolic diseases - Cardiovascular diseases |
| 2016-08-25 | Qinprezo™ (vosaroxin) | acute myeloid leukemia | Sunesis Pharmaceuticals (USA - CA) | Cancer - Oncology | |
| 2016-08-24 | edoxaban | non-valvular atrial fibrillation | 3 | Daiichi Sankyo (Japan) | Cardiovascular diseases |
| 2016-08-22 | GLPG0634 (filgotinib) | rheumatoid arthritis | 3 | Gilead Sciences (USA - CA) Galapagos (Belgium) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
